Reuters logo
BRIEF-Ascendis Pharma A/S reports dosing of subjects in phase 1 trial of transcon pth
September 26, 2017 / 12:33 PM / in 2 months

BRIEF-Ascendis Pharma A/S reports dosing of subjects in phase 1 trial of transcon pth

Sept 26 (Reuters) - Ascendis Pharma A/S:

* Ascendis Pharma A/S announces dosing of subjects in phase 1 trial of Transcon pth

* Ascendis Pharma A/S says ‍phase 1 trial evaluates single ascending doses and ten multiple daily doses of transcon pth​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below